Provided by Tiger Fintech (Singapore) Pte. Ltd.

Yumanity Therapeutics, Inc.

1.89
+0.0000
Volume:- -
Turnover:1.15M
Market Cap:2.93M
PE:-0.09
High:1.89
Open:1.89
Low:1.89
Close:1.89
Loading ...
Apr 08, 2021

Major Issues Report

8-K - Current report
Apr 08, 2021

Major Issues Report

8-K/A [Amend] - Current report
Mar 31, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 31, 2021

Major Issues Report

8-K - Current report
Feb 16, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 12, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2021

Major Issues Report

8-K - Current report
Feb 09, 2021

Correspondence

CORRESP [Cover] - Correspondence
Feb 03, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 03, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 03, 2021

Major Issues Report

8-K/A [Amend] - Current report
Jan 11, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 11, 2021

Major Issues Report

8-K - Current report
Jan 05, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 04, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 04, 2021

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Jan 04, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Dec 30, 2020

Major Issues Report

8-K - Current report
Dec 16, 2020

Major Issues Report

8-K - Current report
Dec 16, 2020

Business Combinations

425 - Prospectuses and communications, business combinations